(Entertainment-NewsWire.com, July 27, 2017 ) According to Publisher, the Global Dietary Supplements market is estimated to be $125.10 billion in 2015 with a CAGR of 7.14% is poised to reach $202.8 billion by 2022. Growing disposable incomes in developing countries, rising awareness towards consumption of proteins, rapidly growing awareness towards calorie drop & weight loss and increasing importance of e-commerce portals as a selling medium for nutraceutical manufacturers are some of the reasons behind the favorable market growth. Moreover, lack of peculiarity from conventional food categories is the critical challenge in this dietary supplements market.
Sports nutrition segment is expected to grow at a faster growth rate during the forecast period due to increasing demand for energy drinks equipped with whey and egg protein between sports athletes and gym professionals. By geography, Asia Pacific witnessed largest market share in 2015 owing to rising disposal income and buyer spending towards nutritional enrichment.
Some of the key players in this market include Himalaya Global Holdings Ltd., Stepan Co., Nutraceutics Inc., Ayanda A/S, Nature’s Sunshine Products, Archer Daniels Midland Company (ADM), Glanbia Nutritionals, Arkopharma Laboratoires Pharmaceutiques, GlaxoSmithKline Pharmaceuticals Ltd, Abbott Laboratories, E. I. du Pont de Nemours and Company, Ekomir Pharma Ltd., Xango, LLC, Bionova Lifesciences (Pragati Biocare Pvt. Ltd.), Pfizer Inc. and Bayer AG.
End User Covered: - Old-aged - Adults - Infant - Pregnant women - Children
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
11 Company Profiling 11.1 Himalaya Global Holdings Ltd. 11.2 Stepan Co. 11.3 Nutraceutics Inc. 11.4 Ayanda A/S 11.5 Nature’s Sunshine Products 11.6 Archer Daniels Midland Company (ADM) 11.7 Glanbia Nutritionals 11.8 Arkopharma Laboratoires Pharmaceutiques 11.9 GlaxoSmithKline Pharmaceuticals Ltd 11.10 Abbott Laboratories 11.11 E. I. du Pont de Nemours and Company 11.12 Ekomir Pharma Ltd. 11.13 Xango, LLC 11.14 Bionova Lifesciences (Pragati Biocare Pvt. Ltd.) 11.15 Pfizer Inc. 11.16 Bayer AG
